CBIO
Vanguard Group’s Crescent Biopharma, Inc. Common Stock CBIO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-2,670,208
| Closed | -$561K | – | 4296 |
|
|
2025
Q1 | $561K | Hold |
2,670,208
| – | – | ﹤0.01% | 3858 |
|
|
2024
Q4 | $665K | Hold |
2,670,208
| – | – | ﹤0.01% | 3868 |
|
|
2024
Q3 | $451K | Sell |
2,670,208
-26,698
| -1% | -$4.51K | ﹤0.01% | 3999 |
|
|
2024
Q2 | $759K | Sell |
2,696,906
-65,075
| -2% | -$18.3K | ﹤0.01% | 3883 |
|
|
2024
Q1 | $8.29M | Buy |
2,761,981
+340,112
| +14% | +$1.02M | ﹤0.01% | 3064 |
|
|
2023
Q4 | $5.72M | Hold |
2,421,869
| – | – | ﹤0.01% | 3227 |
|
|
2023
Q3 | $3.63M | Buy |
2,421,869
+107,464
| +5% | +$161K | ﹤0.01% | 3379 |
|
|
2023
Q2 | $4.03M | Sell |
2,314,405
-146,428
| -6% | -$255K | ﹤0.01% | 3409 |
|
|
2023
Q1 | $3.1M | Buy |
2,460,833
+185,120
| +8% | +$233K | ﹤0.01% | 3513 |
|
|
2022
Q4 | $6.9M | Buy |
2,275,713
+396,301
| +21% | +$1.2M | ﹤0.01% | 3140 |
|
|
2022
Q3 | $1.04M | Buy |
1,879,412
+32,650
| +2% | +$18K | ﹤0.01% | 3987 |
|
|
2022
Q2 | $1.11M | Buy |
1,846,762
+31,799
| +2% | +$19K | ﹤0.01% | 4056 |
|
|
2022
Q1 | $2.07M | Sell |
1,814,963
-423,590
| -19% | -$483K | ﹤0.01% | 3945 |
|
|
2021
Q4 | $3.22M | Sell |
2,238,553
-21,461
| -0.9% | -$30.9K | ﹤0.01% | 3845 |
|
|
2021
Q3 | $4.95M | Sell |
2,260,014
-10,443
| -0.5% | -$22.9K | ﹤0.01% | 3668 |
|
|
2021
Q2 | $5.27M | Sell |
2,270,457
-387,676
| -15% | -$900K | ﹤0.01% | 3574 |
|
|
2021
Q1 | $8M | Buy |
2,658,133
+88,894
| +3% | +$268K | ﹤0.01% | 3277 |
|
|
2020
Q4 | $9.66M | Buy |
2,569,239
+814,623
| +46% | +$3.06M | ﹤0.01% | 3010 |
|
|
2020
Q3 | $5.39M | Buy |
1,754,616
+112,394
| +7% | +$345K | ﹤0.01% | 3110 |
|
|
2020
Q2 | $6.18M | Sell |
1,642,222
-106,029
| -6% | -$399K | ﹤0.01% | 3004 |
|
|
2020
Q1 | $3.99M | Buy |
1,748,251
+3,197
| +0.2% | +$7.29K | ﹤0.01% | 3064 |
|
|
2019
Q4 | $9.23M | Sell |
1,745,054
-5,849
| -0.3% | -$30.9K | ﹤0.01% | 2898 |
|
|
2019
Q3 | $7.55M | Buy |
1,750,903
+11,505
| +0.7% | +$49.6K | ﹤0.01% | 2971 |
|
|
2019
Q2 | $20.7M | Sell |
1,739,398
-96,379
| -5% | -$1.15M | ﹤0.01% | 2495 |
|
|
2019
Q1 | $22.9M | Buy |
1,835,777
+9,750
| +0.5% | +$121K | ﹤0.01% | 2442 |
|
|
2018
Q4 | $17.3M | Buy |
1,826,027
+134,477
| +8% | +$1.27M | ﹤0.01% | 2511 |
|
|
2018
Q3 | $24.4M | Buy |
1,691,550
+26,951
| +2% | +$388K | ﹤0.01% | 2490 |
|
|
2018
Q2 | $26.9M | Buy |
1,664,599
+146,899
| +10% | +$2.37M | ﹤0.01% | 2432 |
|
|
2018
Q1 | $24.6M | Buy |
1,517,700
+484,864
| +47% | +$7.87M | ﹤0.01% | 2418 |
|
|
2017
Q4 | $17.3M | Buy |
1,032,836
+109,592
| +12% | +$1.84M | ﹤0.01% | 2542 |
|
|
2017
Q3 | $12.9M | Buy |
923,244
+79,054
| +9% | +$1.11M | ﹤0.01% | 2695 |
|
|
2017
Q2 | $9.42M | Buy |
844,190
+409,689
| +94% | +$4.57M | ﹤0.01% | 2807 |
|
|
2017
Q1 | $2.36M | Buy |
434,501
+10,057
| +2% | +$54.6K | ﹤0.01% | 3332 |
|
|
2016
Q4 | $2.59M | Buy |
424,444
+15,014
| +4% | +$91.6K | ﹤0.01% | 3274 |
|
|
2016
Q3 | $2.93M | Buy |
409,430
+16,538
| +4% | +$118K | ﹤0.01% | 3243 |
|
|
2016
Q2 | $2.86M | Buy |
392,892
+158,322
| +67% | +$1.15M | ﹤0.01% | 3233 |
|
|
2016
Q1 | $1.4M | Buy |
234,570
+17,568
| +8% | +$105K | ﹤0.01% | 3494 |
|
|
2015
Q4 | $1.24M | Buy |
217,002
+8,500
| +4% | +$48.6K | ﹤0.01% | 3552 |
|
|
2015
Q3 | $1.17M | Hold |
208,502
| – | – | ﹤0.01% | 3582 |
|
|
2015
Q2 | $1.66M | Buy |
208,502
+613
| +0.3% | +$4.88K | ﹤0.01% | 3487 |
|
|
2015
Q1 | $1.73M | Buy |
207,889
+3,324
| +2% | +$27.7K | ﹤0.01% | 3464 |
|
|
2014
Q4 | $1.47M | Buy |
204,565
+1,400
| +0.7% | +$10.1K | ﹤0.01% | 3387 |
|
|
2014
Q3 | $1.41M | Buy |
203,165
+55,830
| +38% | +$387K | ﹤0.01% | 3402 |
|
|
2014
Q2 | $1.24M | Buy |
147,335
+21,535
| +17% | +$182K | ﹤0.01% | 3434 |
|
|
2014
Q1 | $2.05M | Buy |
+125,800
| New | +$2.05M | ﹤0.01% | 3209 |
|